Transforming scientific discoveries into therapeutic innovations is a long and difficult process that requires the integration of multidisciplinary capabilities and creative input.  Tyligand has established collaborations with KOLs from multiple hospitals, universities, and technology companies across the globe for clinical trials, target biology, pharmacology, and toxicology research.  

As our R&D pipeline advances through clinical trials, we will continue to explore and expand opportunities to grow together with our partners, and strive to win the trust and support from the global scientific community, with our integrity, quality, and excellence in execution. 

Please contact us at BD@tyligand.com, and we look forward to hearing from you !